Header Logo

Nicola Klein

Concepts (458)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vaccination
116
2025
656
12.760
Why?
Influenza Vaccines
49
2025
275
10.750
Why?
Influenza, Human
36
2025
267
9.290
Why?
Vaccines
36
2025
218
6.630
Why?
Diphtheria-Tetanus-acellular Pertussis Vaccines
25
2025
88
5.730
Why?
Whooping Cough
17
2023
66
5.640
Why?
Humans
254
2025
17707
5.500
Why?
Child
97
2025
2481
5.110
Why?
Immunization
19
2025
70
4.460
Why?
Infant
78
2025
1199
4.120
Why?
Hospitalization
35
2025
805
3.870
Why?
Measles-Mumps-Rubella Vaccine
13
2022
62
3.840
Why?
Female
165
2025
12729
3.830
Why?
Meningococcal Vaccines
11
2022
39
3.750
Why?
Chickenpox Vaccine
18
2022
91
3.700
Why?
Adolescent
86
2025
3671
3.440
Why?
Child, Preschool
61
2025
1417
3.390
Why?
Male
122
2025
10094
3.320
Why?
Immunization Schedule
21
2024
122
3.130
Why?
Pregnancy Complications, Infectious
16
2025
147
2.950
Why?
Measles
6
2022
24
2.850
Why?
Antibodies, Bacterial
19
2023
33
2.810
Why?
Product Surveillance, Postmarketing
16
2018
95
2.780
Why?
Adult
101
2025
7658
2.750
Why?
Papillomavirus Vaccines
13
2024
113
2.700
Why?
Seizures, Febrile
8
2022
42
2.640
Why?
Young Adult
70
2025
2450
2.620
Why?
Vaccines, Combined
21
2023
80
2.510
Why?
Vaccination Coverage
10
2025
45
2.500
Why?
United States
73
2025
3914
2.500
Why?
California
44
2025
2327
2.410
Why?
Pericarditis
3
2022
11
2.380
Why?
Myocarditis
3
2022
14
2.370
Why?
Retrospective Studies
56
2025
2471
2.310
Why?
Vaccines, Conjugate
18
2023
59
2.230
Why?
Poliovirus Vaccine, Inactivated
9
2020
21
2.220
Why?
Incidence
34
2024
1269
2.090
Why?
Pneumococcal Infections
7
2023
42
2.060
Why?
Herpes Zoster
6
2023
82
1.990
Why?
Herpes Zoster Vaccine
6
2023
59
1.980
Why?
Pneumococcal Vaccines
10
2025
66
1.930
Why?
Papillomavirus Infections
11
2024
139
1.910
Why?
Immunization, Secondary
14
2022
57
1.890
Why?
Pregnancy
41
2025
1535
1.850
Why?
Meningococcal Infections
7
2019
17
1.850
Why?
Fever
7
2022
55
1.840
Why?
Emergency Service, Hospital
15
2025
377
1.820
Why?
Drug-Related Side Effects and Adverse Reactions
19
2017
107
1.800
Why?
Diphtheria-Tetanus-Pertussis Vaccine
8
2020
23
1.790
Why?
Pregnancy Outcome
8
2025
162
1.760
Why?
Immunogenicity, Vaccine
7
2024
12
1.690
Why?
Infant, Newborn
31
2025
857
1.630
Why?
Pertussis Vaccine
6
2020
14
1.620
Why?
Cohort Studies
38
2023
2589
1.610
Why?
Pneumonia, Pneumococcal
2
2023
13
1.590
Why?
Haemophilus Vaccines
6
2020
17
1.590
Why?
Vaccines, Inactivated
10
2023
68
1.570
Why?
Vaccines, Synthetic
9
2024
34
1.570
Why?
Mumps
3
2020
12
1.550
Why?
Neuralgia, Postherpetic
2
2023
12
1.510
Why?
Middle Aged
49
2025
7976
1.430
Why?
Adverse Drug Reaction Reporting Systems
20
2021
93
1.380
Why?
Disease Outbreaks
5
2020
36
1.370
Why?
Antibodies, Viral
13
2024
65
1.360
Why?
Time Factors
23
2022
1095
1.320
Why?
Guillain-Barre Syndrome
4
2022
15
1.320
Why?
Case-Control Studies
24
2024
1117
1.310
Why?
Aged
35
2025
6150
1.290
Why?
Rotavirus Vaccines
9
2025
52
1.080
Why?
Immunization Programs
7
2025
65
1.040
Why?
Vaccination Refusal
3
2020
9
1.020
Why?
RNA, Messenger
11
2024
72
1.000
Why?
Neisseria meningitidis
4
2019
10
0.990
Why?
Abortion, Spontaneous
7
2023
47
0.990
Why?
Intensive Care Units, Neonatal
3
2011
41
0.970
Why?
Pneumonia
2
2023
51
0.930
Why?
Herpesvirus 3, Human
5
2023
44
0.930
Why?
Prenatal Care
4
2020
129
0.900
Why?
Herpes Zoster Ophthalmicus
1
2023
1
0.880
Why?
Seasons
10
2025
105
0.850
Why?
Tetanus
5
2023
17
0.840
Why?
Measles Vaccine
3
2022
17
0.820
Why?
Autoimmune Diseases
3
2012
20
0.810
Why?
Adaptive Immunity
1
2022
1
0.790
Why?
Sepsis
2
2015
70
0.780
Why?
Premature Birth
8
2023
141
0.780
Why?
Vaccines, Attenuated
10
2023
45
0.770
Why?
Risk Assessment
16
2020
1106
0.770
Why?
Immunologic Factors
1
2022
29
0.770
Why?
Cluster Analysis
3
2023
90
0.770
Why?
Influenza A Virus, H1N1 Subtype
7
2024
52
0.770
Why?
Seizures
4
2014
29
0.740
Why?
Asthma
4
2022
385
0.740
Why?
Communicable Disease Control
2
2011
18
0.740
Why?
Streptococcus pneumoniae
7
2023
19
0.720
Why?
Rubella
1
2020
6
0.710
Why?
Influenza A virus
2
2020
13
0.700
Why?
Follow-Up Studies
11
2020
1218
0.690
Why?
Hearing Loss, Sensorineural
2
2020
7
0.690
Why?
Education, Medical, Continuing
1
2020
30
0.680
Why?
Family Practice
1
2020
43
0.680
Why?
Eggs
1
2020
8
0.680
Why?
Risk Factors
17
2024
3367
0.680
Why?
Blood Bactericidal Activity
6
2019
10
0.670
Why?
Autism Spectrum Disorder
2
2022
165
0.660
Why?
Aged, 80 and over
16
2025
1927
0.640
Why?
Logistic Models
9
2020
918
0.640
Why?
Diphtheria
4
2016
13
0.640
Why?
Chorioamnionitis
4
2023
18
0.630
Why?
Stillbirth
5
2024
29
0.620
Why?
Pediatrics
1
2020
156
0.610
Why?
Data Collection
7
2021
252
0.610
Why?
Ambulatory Care
5
2024
241
0.600
Why?
Risk
14
2021
517
0.600
Why?
Infant, Premature
2
2010
62
0.600
Why?
Antibody Formation
1
2018
7
0.590
Why?
Meningitis, Meningococcal
1
2018
7
0.590
Why?
Respiratory Tract Infections
3
2023
48
0.590
Why?
Haemophilus Infections
2
2017
5
0.580
Why?
Mothers
3
2023
106
0.580
Why?
Severity of Illness Index
3
2024
448
0.570
Why?
Vaccine Potency
1
2017
4
0.560
Why?
Encephalomyelitis, Acute Disseminated
2
2016
4
0.560
Why?
Status Asthmaticus
1
2017
1
0.560
Why?
Immunization, Passive
1
2017
3
0.560
Why?
Tetanus Toxoid
5
2018
11
0.540
Why?
Myelitis, Transverse
1
2016
4
0.530
Why?
Schools
6
2025
87
0.530
Why?
Optic Neuritis
1
2016
3
0.520
Why?
Hearing Loss, Sudden
1
2016
1
0.520
Why?
Research Design
1
2018
372
0.520
Why?
Health Knowledge, Attitudes, Practice
7
2022
381
0.510
Why?
Serogroup
3
2021
10
0.500
Why?
Infant, Extremely Low Birth Weight
1
2015
3
0.490
Why?
Health Policy
3
2022
118
0.490
Why?
Intubation, Intratracheal
1
2015
6
0.490
Why?
Bell Palsy
2
2012
14
0.490
Why?
Respiration, Artificial
1
2015
37
0.480
Why?
Databases, Factual
7
2025
311
0.480
Why?
Odds Ratio
7
2023
670
0.480
Why?
Papillomaviridae
2
2020
58
0.460
Why?
Age Factors
9
2021
918
0.460
Why?
Hepatitis B Vaccines
5
2020
43
0.460
Why?
Chronic Disease
2
2016
416
0.450
Why?
Infant, Small for Gestational Age
5
2017
58
0.450
Why?
Hepatitis A Vaccines
4
2019
14
0.440
Why?
Population Surveillance
4
2025
265
0.440
Why?
Chickenpox
2
2020
35
0.440
Why?
Respiratory Syncytial Virus Infections
2
2024
29
0.430
Why?
Penile Diseases
1
2013
1
0.430
Why?
Urethral Diseases
1
2013
1
0.430
Why?
Vulvar Diseases
1
2013
1
0.430
Why?
Uterine Cervical Diseases
1
2013
2
0.430
Why?
Proportional Hazards Models
5
2023
710
0.430
Why?
Vaginal Diseases
1
2013
6
0.430
Why?
Condylomata Acuminata
1
2013
23
0.420
Why?
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
4
2017
32
0.410
Why?
Skin Diseases, Bacterial
1
2012
5
0.410
Why?
Syncope
1
2012
12
0.410
Why?
Intussusception
4
2014
16
0.410
Why?
Mandatory Programs
2
2025
6
0.410
Why?
Critical Illness
2
2023
50
0.400
Why?
Apnea
2
2010
3
0.380
Why?
Health Personnel
1
2013
123
0.380
Why?
Uterine Cervical Neoplasms
4
2022
125
0.380
Why?
Immunologic Memory
2
2013
3
0.370
Why?
Metabolism, Inborn Errors
1
2011
2
0.370
Why?
Vaccines, Acellular
5
2020
11
0.360
Why?
Database Management Systems
3
2020
14
0.360
Why?
Insurance, Health
3
2021
175
0.360
Why?
Rotavirus
2
2021
18
0.360
Why?
Parents
4
2022
295
0.360
Why?
Biomedical Research
1
2011
82
0.350
Why?
T-Lymphocytes
1
2010
8
0.340
Why?
Pamphlets
1
2009
7
0.330
Why?
Diabetes Mellitus, Type 1
2
2021
121
0.330
Why?
Patient Discharge
1
2011
153
0.320
Why?
Rotavirus Infections
3
2021
31
0.320
Why?
Immunocompromised Host
2
2021
18
0.320
Why?
Viral Vaccines
2
2023
12
0.320
Why?
src-Family Kinases
2
1999
2
0.310
Why?
Congenital Abnormalities
3
2017
26
0.310
Why?
Prospective Studies
10
2023
1287
0.300
Why?
CD4-Positive T-Lymphocytes
2
2017
14
0.300
Why?
Epidemiologic Methods
2
2017
80
0.290
Why?
Electronic Health Records
6
2023
694
0.280
Why?
Respiratory Syncytial Virus, Human
2
2024
21
0.270
Why?
Patient Acceptance of Health Care
2
2020
387
0.260
Why?
CD8-Positive T-Lymphocytes
1
2006
5
0.260
Why?
Surveys and Questionnaires
5
2025
1322
0.260
Why?
Cross-Sectional Studies
8
2024
1322
0.250
Why?
Venous Thromboembolism
2
2017
53
0.250
Why?
Immunoglobulin G
4
2021
29
0.240
Why?
HIV Infections
2
2024
704
0.240
Why?
Educational Personnel
1
2025
1
0.240
Why?
Aluminum
2
2022
14
0.240
Why?
Delivery of Health Care, Integrated
5
2024
531
0.240
Why?
Bacterial Capsules
2
2017
5
0.240
Why?
Treatment Outcome
3
2021
1254
0.230
Why?
Respiratory Syncytial Virus Vaccines
1
2024
8
0.230
Why?
Influenza A Virus, H3N2 Subtype
1
2024
15
0.230
Why?
Gonorrhea
1
2024
18
0.230
Why?
Chlamydia Infections
1
2024
22
0.230
Why?
Animals
3
2020
262
0.220
Why?
Mortality
2
2021
118
0.210
Why?
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
2022
4
0.210
Why?
Poisson Distribution
4
2016
88
0.210
Why?
Polymerase Chain Reaction
2
2013
49
0.210
Why?
Respiratory Tract Diseases
2
2020
24
0.210
Why?
Pharyngitis
1
2022
10
0.200
Why?
Sex Factors
3
2021
639
0.200
Why?
Intention
1
2022
28
0.200
Why?
School Health Services
2
2021
39
0.200
Why?
Eczema
1
2022
7
0.200
Why?
Practice Guidelines as Topic
2
2021
314
0.200
Why?
Confidence Intervals
3
2021
237
0.190
Why?
Pregnant Women
2
2020
46
0.190
Why?
China
1
2022
132
0.190
Why?
Hepatitis A
2
2019
10
0.190
Why?
Intensive Care Units
2
2024
103
0.190
Why?
Centers for Disease Control and Prevention (U.S.)
4
2014
32
0.190
Why?
Trans-Activators
2
1999
8
0.190
Why?
Antibodies, Neutralizing
1
2021
6
0.190
Why?
ras Proteins
2
1999
20
0.190
Why?
Physicians, Primary Care
1
2022
71
0.180
Why?
Inflammatory Bowel Diseases
1
2021
18
0.180
Why?
Regression Analysis
3
2016
296
0.180
Why?
Heptavalent Pneumococcal Conjugate Vaccine
3
2021
15
0.180
Why?
Nervous System Diseases
2
2011
19
0.180
Why?
Mental Disorders
1
2024
276
0.180
Why?
Circovirus
1
2020
1
0.180
Why?
Spatial Analysis
1
2020
11
0.180
Why?
Geography
1
2020
39
0.180
Why?
Linguistics
1
2020
4
0.180
Why?
Pregnancy Trimester, First
2
2017
40
0.170
Why?
Prognosis
2
2020
613
0.170
Why?
Complement System Proteins
2
2018
4
0.170
Why?
Europe
1
2020
42
0.170
Why?
Education
1
2020
16
0.170
Why?
Professional-Family Relations
1
2020
48
0.170
Why?
Bacterial Infections
1
2019
9
0.170
Why?
Diphtheria Toxoid
2
2017
3
0.170
Why?
Epidemiological Monitoring
1
2019
25
0.170
Why?
Virus Replication
1
1999
13
0.170
Why?
Bacterial Vaccines
2
2023
9
0.160
Why?
Hepatitis A Virus, Human
1
2019
5
0.160
Why?
Hepatitis B virus
1
1999
20
0.160
Why?
Coronavirus Infections
1
2020
48
0.160
Why?
Pneumonia, Viral
1
2020
55
0.160
Why?
Frail Elderly
1
2019
9
0.160
Why?
Frailty
1
2019
10
0.160
Why?
History, 21st Century
2
2019
24
0.160
Why?
Qualitative Research
1
2020
257
0.160
Why?
Outcome Assessment (Health Care)
2
2018
227
0.160
Why?
Epidemiologic Research Design
2
2016
18
0.150
Why?
Gestational Age
3
2021
116
0.150
Why?
Hispanic Americans
1
2020
397
0.150
Why?
Models, Theoretical
1
2018
68
0.150
Why?
Residence Characteristics
1
2020
248
0.150
Why?
Rabbits
1
2018
6
0.150
Why?
Infant Mortality
1
2018
19
0.150
Why?
Vaccines, Subunit
1
2017
1
0.150
Why?
Microcephaly
1
2017
3
0.150
Why?
Respiratory Distress Syndrome, Newborn
1
2017
6
0.150
Why?
Bordetella pertussis
2
2020
4
0.150
Why?
Multivariate Analysis
4
2017
561
0.150
Why?
Adjuvants, Immunologic
1
2017
16
0.140
Why?
Abnormalities, Drug-Induced
1
2017
15
0.140
Why?
Licensure
1
2017
5
0.140
Why?
Infant, Very Low Birth Weight
1
2017
9
0.140
Why?
African Americans
1
2020
465
0.140
Why?
Uterine Cervical Dysplasia
1
2017
8
0.140
Why?
Haemophilus influenzae type b
1
2017
2
0.140
Why?
Preconception Care
1
2017
44
0.140
Why?
Safety Management
3
2011
13
0.140
Why?
Patient Compliance
1
2019
299
0.140
Why?
Decision Making
1
2018
182
0.140
Why?
Health Maintenance Organizations
2
2010
414
0.140
Why?
Infant, Newborn, Diseases
1
2017
36
0.140
Why?
Family Health
1
2017
44
0.140
Why?
Pregnancy Complications
2
2017
203
0.130
Why?
Maternal Age
3
2023
77
0.130
Why?
Pandemics
3
2024
286
0.130
Why?
Liver Diseases
1
2016
23
0.130
Why?
Epidemiologic Studies
1
2016
29
0.130
Why?
Anaphylaxis
1
2015
16
0.120
Why?
Autistic Disorder
1
2017
100
0.120
Why?
Causality
2
2012
39
0.120
Why?
Double-Blind Method
3
2021
160
0.120
Why?
Immunity, Cellular
2
2017
4
0.120
Why?
Comorbidity
4
2022
590
0.120
Why?
Biomarkers, Pharmacological
1
2015
5
0.120
Why?
Sex Distribution
2
2017
189
0.120
Why?
Prenatal Exposure Delayed Effects
1
2017
167
0.120
Why?
Communicable Diseases, Emerging
1
2014
1
0.120
Why?
History, 20th Century
1
2014
9
0.120
Why?
Treatment Refusal
1
2015
33
0.120
Why?
Age Distribution
2
2017
246
0.120
Why?
Mucocutaneous Lymph Node Syndrome
1
2014
18
0.120
Why?
Algorithms
2
2017
237
0.120
Why?
Medical Records
2
2017
97
0.110
Why?
DiGeorge Syndrome
1
2014
2
0.110
Why?
Pulmonary Disease, Chronic Obstructive
1
2016
196
0.110
Why?
Safety
2
2011
41
0.110
Why?
Hypertension, Pregnancy-Induced
1
2014
46
0.110
Why?
Opsonin Proteins
1
2013
1
0.110
Why?
Phagocytosis
1
2013
2
0.110
Why?
Health Education
2
2011
110
0.110
Why?
Attitude to Health
1
2015
159
0.110
Why?
Sexually Transmitted Diseases, Viral
1
2013
2
0.110
Why?
Gastrointestinal Diseases
1
2013
27
0.110
Why?
Carcinoma in Situ
1
2013
17
0.100
Why?
Cervical Intraepithelial Neoplasia
1
2013
16
0.100
Why?
Alphapapillomavirus
1
2013
13
0.100
Why?
Graves Disease
1
2012
3
0.100
Why?
Drug Evaluation
1
2012
6
0.100
Why?
Hospital Mortality
2
2023
145
0.100
Why?
Stroke
2
2019
316
0.100
Why?
Laboratories
2
2021
18
0.090
Why?
Prevalence
4
2017
882
0.090
Why?
Advisory Committees
2
2024
112
0.090
Why?
Adenocarcinoma
1
2013
173
0.090
Why?
Information Services
1
2011
11
0.090
Why?
Arthritis, Rheumatoid
1
2011
22
0.090
Why?
Reference Values
1
2011
93
0.090
Why?
Needs Assessment
1
2011
69
0.090
Why?
Length of Stay
1
2011
182
0.090
Why?
Anti-Bacterial Agents
2
2022
137
0.090
Why?
Hematologic Diseases
1
2010
3
0.090
Why?
Hypersensitivity
1
2010
18
0.090
Why?
Antipyretics
1
2010
4
0.090
Why?
Physical Examination
1
2010
20
0.080
Why?
Flow Cytometry
1
2010
5
0.080
Why?
Monocytes
1
2010
5
0.080
Why?
Medical Audit
1
2010
35
0.080
Why?
Information Systems
1
2009
19
0.080
Why?
Public Health Surveillance
2
2019
42
0.080
Why?
Longitudinal Studies
2
2014
717
0.080
Why?
Enzyme Activation
2
1999
6
0.080
Why?
Brain Ischemia
1
2009
37
0.080
Why?
Signal Transduction
2
1999
30
0.080
Why?
Mumps Vaccine
1
2008
7
0.070
Why?
Rubella Vaccine
1
2008
8
0.070
Why?
Poliomyelitis
1
2008
2
0.070
Why?
Bias
2
2020
103
0.070
Why?
Medicaid
2
2025
188
0.070
Why?
Serotyping
1
2007
3
0.070
Why?
Sentinel Surveillance
1
2007
12
0.070
Why?
Injections, Intramuscular
2
2021
9
0.070
Why?
Twins
1
2007
11
0.070
Why?
Diseases in Twins
1
2007
15
0.070
Why?
Siblings
1
2007
12
0.070
Why?
Predictive Value of Tests
1
2008
355
0.070
Why?
Medication Adherence
1
2009
245
0.070
Why?
Single-Blind Method
2
2020
45
0.070
Why?
Mass Vaccination
2
2019
22
0.070
Why?
Interferon-gamma
1
2006
8
0.070
Why?
Propensity Score
2
2017
85
0.070
Why?
Sex Characteristics
1
2006
69
0.060
Why?
Drug Administration Schedule
2
2020
100
0.060
Why?
Registries
1
2008
470
0.060
Why?
International Classification of Diseases
2
2017
85
0.060
Why?
Genetic Predisposition to Disease
1
2007
377
0.060
Why?
Toxoids
1
2023
3
0.050
Why?
Oxygen
1
2023
16
0.050
Why?
Macrolides
1
2022
7
0.050
Why?
Penicillins
1
2022
5
0.050
Why?
Early Detection of Cancer
2
2022
513
0.050
Why?
Inappropriate Prescribing
1
2022
8
0.050
Why?
RNA, Messenger, Stored
1
2022
3
0.050
Why?
Electronics
1
2022
4
0.050
Why?
Human papillomavirus 18
1
2022
3
0.050
Why?
Human papillomavirus 16
1
2022
7
0.050
Why?
Antiviral Agents
1
2022
94
0.050
Why?
Alberta
1
2021
3
0.050
Why?
Antigens
1
2021
7
0.050
Why?
Postal Service
1
2022
73
0.050
Why?
Drug Approval
1
2021
12
0.050
Why?
Forecasting
1
2022
74
0.050
Why?
Data Interpretation, Statistical
1
2021
75
0.050
Why?
Drug Prescriptions
1
2022
151
0.050
Why?
Systemic Inflammatory Response Syndrome
1
2021
9
0.050
Why?
Ambulatory Care Facilities
1
2021
67
0.050
Why?
Pain
1
2021
79
0.040
Why?
Child Health Services
1
2022
106
0.040
Why?
Policy
1
2020
18
0.040
Why?
Perception
1
2021
57
0.040
Why?
National Institute of Allergy and Infectious Diseases (U.S.)
1
2020
1
0.040
Why?
Health Facilities
1
2020
16
0.040
Why?
Attitude
1
2020
30
0.040
Why?
Global Health
1
2020
31
0.040
Why?
Managed Care Programs
2
2013
313
0.040
Why?
Disease Susceptibility
1
2020
37
0.040
Why?
Drug Hypersensitivity
1
2019
9
0.040
Why?
Appendicitis
1
2019
15
0.040
Why?
Practice Patterns, Physicians'
1
2022
324
0.040
Why?
Hepatitis B Virus, Woodchuck
1
1999
1
0.040
Why?
Viral Proteins
1
1999
2
0.040
Why?
DNA Primers
1
1999
7
0.040
Why?
Cell Line
1
1999
10
0.040
Why?
Base Sequence
1
1999
19
0.040
Why?
Health Status Disparities
1
2021
147
0.040
Why?
RNA, Viral
1
1999
65
0.040
Why?
Continental Population Groups
1
2021
301
0.040
Why?
Cerebrovascular Disorders
1
2019
34
0.040
Why?
Pancreatitis
1
2019
50
0.040
Why?
Mass Screening
1
2024
667
0.040
Why?
Viral Load
1
2019
136
0.040
Why?
Respiratory Sounds
1
2018
12
0.040
Why?
Hepatitis B
1
2018
42
0.040
Why?
Adjuvants, Pharmaceutic
1
2017
1
0.040
Why?
Viral Envelope Proteins
1
2017
2
0.040
Why?
Immunity, Humoral
1
2017
4
0.040
Why?
Ethnic Groups
1
2021
474
0.040
Why?
Guanosine Triphosphate
1
1997
1
0.040
Why?
Transcriptional Activation
1
1997
1
0.040
Why?
3T3 Cells
1
1997
1
0.040
Why?
Transcription Factor AP-1
1
1997
1
0.040
Why?
GTPase-Activating Proteins
1
1997
1
0.040
Why?
ras GTPase-Activating Proteins
1
1997
1
0.040
Why?
Viral Regulatory and Accessory Proteins
1
1997
1
0.040
Why?
Proteins
1
1997
16
0.040
Why?
Mice
1
1997
69
0.040
Why?
Venous Thrombosis
1
2017
21
0.040
Why?
Equivalence Trials as Topic
1
2017
1
0.030
Why?
Infant, Low Birth Weight
1
2017
34
0.030
Why?
Influenza B virus
1
2017
9
0.030
Why?
Pulmonary Embolism
1
2017
44
0.030
Why?
Cause of Death
1
2018
181
0.030
Why?
Proof of Concept Study
1
2016
2
0.030
Why?
Dose-Response Relationship, Drug
1
2017
128
0.030
Why?
Child Development Disorders, Pervasive
1
2017
33
0.030
Why?
Pregnancy Trimesters
1
2016
30
0.030
Why?
Observational Studies as Topic
1
2016
47
0.030
Why?
Postpartum Period
1
2016
99
0.030
Why?
Topography, Medical
1
2015
5
0.030
Why?
Utilization Review
1
2015
48
0.030
Why?
Vasculitis
1
2014
2
0.030
Why?
Contraindications
1
2014
14
0.030
Why?
Cooperative Behavior
1
2014
89
0.030
Why?
Emergency Medical Services
1
2013
48
0.030
Why?
Papanicolaou Test
1
2013
37
0.030
Why?
Neoplasm Grading
1
2013
49
0.030
Why?
Vaginal Smears
1
2013
48
0.030
Why?
Vaccines, Live, Unattenuated
1
2012
1
0.030
Why?
Narcolepsy
1
2012
6
0.030
Why?
Cranial Nerve Diseases
1
2011
2
0.020
Why?
Hepatitis A Antibodies
1
2011
2
0.020
Why?
Monitoring, Immunologic
1
2011
4
0.020
Why?
Role
1
2011
3
0.020
Why?
Tennessee
1
2011
6
0.020
Why?
Recurrence
1
2012
189
0.020
Why?
Comprehension
1
2011
17
0.020
Why?
Culture
1
2011
26
0.020
Why?
Academic Medical Centers
1
2011
30
0.020
Why?
Bacterial Proteins
1
2010
13
0.020
Why?
Randomized Controlled Trials as Topic
1
2012
327
0.020
Why?
Referral and Consultation
1
2011
165
0.020
Why?
Concepts (458)
Explore
_
Co-Authors (28)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_
-->

© 2025 Kaiser Permanente